 MORRISVILLE, N.C., May 24, 2022 GLOBE NEWSWIRE -- Syneos Health Nasdaq:SYNH, the only fully integrated biopharmaceutical solutions organization, announced that the Company is scheduled to present at two upcoming investor conferences. Chief Executive Officer Michelle Keefe and Chief Financial Officer Jason Meggs are scheduled to present at the following conferences: 